ANSTO Health News
Four million nuclear medicine doses produced
ANSTO has produced its four millionth patient dose of Australian nuclear medicine, which is used to diagnose a wide range of illnesses, including cardiac conditions, cancers and skeletal injuries
Ground floor of new ANM facility nears completion
Australia’s new nuclear medicine manufacturing facility is taking shape. This project which will enable Australia to help meet world demand for the most common radionuclide used in nuclear medicine, Molybdenum-99.